No Data
No Data
No Data
No Data
No Data
Barclays Sticks to Their Buy Rating for Revance Therapeutics (RVNC)
TipRanksApr 23 05:59 ET
OPI, RVNC and AQST Are Among After Hour Movers
Seeking AlphaApr 22 16:53 ET
AbbVie Working With FDA After Reports of Fake Botox Versions
Seeking AlphaApr 16 10:47 ET
Revance To Present New DAXXIFY Data At The American Academy Of Neurology 2024 Annual Meeting
– Two presentations highlighting data on DAXXIFY for the treatment of cervical dystonia, including a new analysis from ASPEN trials assessing patient-desired retreatment intervals and one abstract exa
BenzingaApr 12 08:01 ET
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday.
BenzingaApr 9 10:43 ET
Take Care Before Jumping Onto Revance Therapeutics, Inc. (NASDAQ:RVNC) Even Though It's 35% Cheaper
To the annoyance of some shareholders, Revance Therapeutics, Inc. (NASDAQ:RVNC) shares are down a considerable 35% in the last month, which continues a horrid run for the company. For any long-term
Simply Wall StApr 3 12:03 ET
No Data
No Data